Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Journal of Molecular Medicine (Berlin, Germany)|October 22, 2022
WWOX and metabolic regulation in normal and pathological conditionsIzabela Baryła, Katarzyna Kośla, Andrzej K BednarekMaterials (Basel, Switzerland)|September 23, 2022
Influence of the Accelerated Aging Process on the Fragment-Resistant Properties of Para-Aramid Body ArmorKatarzyna Kośla, Marcin Łandwijt, Michał Miklas, et al.Oncology Reports|July 23, 2014
WWOX modulates the gene expression profile in the T98G glioblastoma cell line rendering its phenotype less malignantKatarzyna Kośla, Magdalena Nowakowska, Karolina Pospiech, et al.Materials (Basel, Switzerland)|March 25, 2022
Fragment-Resistant Property Optimization within Ballistic Inserts Obtained on the Basis of Para-Aramid MaterialsKatarzyna Kośla, Paweł Kubiak, Marcin Łandwijt, et al.Polish Journal of Radiology|October 11, 2012
Functional rearrangement of language areas in patients with tumors of the central nervous system using functional magnetic resonance imagingKatarzyna Kośla, Lucjan Pfajfer, Bartosz Bryszewski, et al.International Journal of Molecular Medicine|October 16, 2013
The WWOX tumor suppressor gene in endometrial adenocarcinomaElżbieta Płuciennik, Katarzyna Kośla, Katarzyna Wójcik-Krowiranda, et al.International Journal of Molecular Sciences|March 25, 2022
The <i>WWOX/HIF1A</i> Axis Downregulation Alters Glucose Metabolism and Predispose to Metabolic DisordersIzabela Baryła, Ewa Styczeń-Binkowska, Elżbieta Płuciennik, et al.Biology|March 29, 2023
Antineoplastic Nature of <i>WWOX</i> in Glioblastoma Is Mainly a Consequence of Reduced Cell Viability and InvasionŻaneta Kałuzińska-Kołat, Katarzyna Kośla, Damian Kołat, et al.Polymers|August 2, 2019
Effect of Accelerated Ageing on the Mechanical and Structural Properties of the Material System Used in ProtectorsLongina Madej-Kiełbik, Katarzyna Kośla, Dorota Zielińska, et al.Frontiers in Neuroscience|October 2, 2023
Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from <i>WWOX</i> tumor suppressor expressionŻaneta Kałuzińska-Kołat, Damian Kołat, Katarzyna Kośla, et al.Pageof 3